Source: Journal of Oral Pathology & Medicine. Unidades: FCFRP, FORP
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, FARMACOTERAPIA, LINHAGEM CELULAR, NEOPLASIAS, NEOPLASIAS DE CABEÇA E PESCOÇO, NEOPLASIAS BUCAIS, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Marcela de Oliveira et al. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, v. 51, n. 6, p. 529-537, 2022Tradução . . Disponível em: https://doi.org/10.1111/jop.13326. Acesso em: 03 nov. 2024.APA
Tavares, M. de O., Milan, T. M., Bighetti-Trevisan, R. L., Leopoldino, A. M., & Almeida, L. O. de. (2022). Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 51( 6), 529-537. doi:10.1111/jop.13326NLM
Tavares M de O, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, Almeida LO de. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma [Internet]. Journal of Oral Pathology & Medicine. 2022 ; 51( 6): 529-537.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/jop.13326Vancouver
Tavares M de O, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, Almeida LO de. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma [Internet]. Journal of Oral Pathology & Medicine. 2022 ; 51( 6): 529-537.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/jop.13326